Additionally, indirect TRAIL-induced pro-survival signaling via EGFR/HER2 has been reported in colorectal cancer cells [44], which provides further rationale for combination of TRAIL with EGFR- and HER2-blocking molecules. Here, TNFSF10 is linked to colorectal cancer.